Publications dans lesquelles il/elle collabore avec Nicolás Merchante Gutiérrez (25)

2020

  1. Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 3, pp. 127-131

  2. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 1, pp. 28-32

  3. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

    AIDS (London, England), Vol. 34, Núm. 10, pp. 1497-1507

  4. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 71, Núm. 9, pp. 2354-2362

  5. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 71, Núm. 11, pp. 2810-2817

2019

  1. Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients

    Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 48-54

  2. Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection

    Scientific Reports, Vol. 9, Núm. 1

  3. Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients

    AIDS, Vol. 33, Núm. 2, pp. 269-278

  4. Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection

    Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 16-24

2018

  1. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

    AIDS, Vol. 32, Núm. 11, pp. 1423-1430

  2. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 9, pp. 2435-2443

2017

  1. Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus-infected patients with nonalcoholic fatty liver disease

    Clinical Infectious Diseases, Vol. 65, Núm. 6, pp. 1012-1019

  2. Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients

    HIV Medicine, Vol. 18, Núm. 8, pp. 546-554

  3. Liver stiffness predicts variceal bleeding in HIV/HCVcoinfected patients with compensated cirrhosis

    AIDS, Vol. 31, Núm. 4, pp. 493-500

  4. Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients

    AIDS, Vol. 31, Núm. 1, pp. 89-95

  5. Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

    Clinical Microbiology and Infection, Vol. 23, Núm. 6, pp. 409.e5-409.e8

2016

  1. The PNPLA3 genetic variant rs738409 influences the progression to cirrhosis in HIV/ Hepatitis C virus coinfected patients

    PLoS ONE, Vol. 11, Núm. 12

2015

  1. Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C

    Journal of Infection, Vol. 71, Núm. 5, pp. 571-577

  2. Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals

    AIDS, Vol. 29, Núm. 15, pp. 1927-1935

  3. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term

    Hepatology, Vol. 61, Núm. 5, pp. 1503-1511